JPS63237788A - Novel multi-copying plasmid - Google Patents
Novel multi-copying plasmidInfo
- Publication number
- JPS63237788A JPS63237788A JP62070217A JP7021787A JPS63237788A JP S63237788 A JPS63237788 A JP S63237788A JP 62070217 A JP62070217 A JP 62070217A JP 7021787 A JP7021787 A JP 7021787A JP S63237788 A JPS63237788 A JP S63237788A
- Authority
- JP
- Japan
- Prior art keywords
- plasmid
- strain
- pnb701
- pnb
- restriction enzyme
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000013612 plasmid Substances 0.000 title claims abstract description 56
- 108091008146 restriction endonucleases Proteins 0.000 claims abstract description 16
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 12
- 238000003776 cleavage reaction Methods 0.000 claims description 7
- 230000007017 scission Effects 0.000 claims description 7
- 239000000126 substance Substances 0.000 claims description 5
- 206010059866 Drug resistance Diseases 0.000 claims description 3
- 210000004027 cell Anatomy 0.000 abstract description 12
- 241000970854 Streptomyces violaceusniger Species 0.000 abstract description 7
- 230000010076 replication Effects 0.000 abstract description 4
- 239000011543 agarose gel Substances 0.000 abstract description 3
- 238000002298 density-gradient ultracentrifugation Methods 0.000 abstract description 3
- 102000004169 proteins and genes Human genes 0.000 abstract description 3
- 238000010367 cloning Methods 0.000 abstract description 2
- 239000000356 contaminant Substances 0.000 abstract description 2
- 230000009089 cytolysis Effects 0.000 abstract description 2
- 239000013598 vector Substances 0.000 abstract description 2
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 abstract 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 abstract 1
- 210000005056 cell body Anatomy 0.000 abstract 1
- 108020004414 DNA Proteins 0.000 description 14
- 230000001580 bacterial effect Effects 0.000 description 10
- 241000187747 Streptomyces Species 0.000 description 9
- 239000002609 medium Substances 0.000 description 9
- 238000000034 method Methods 0.000 description 8
- 238000001962 electrophoresis Methods 0.000 description 7
- 239000000243 solution Substances 0.000 description 7
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 6
- 229920001817 Agar Polymers 0.000 description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 5
- 239000008272 agar Substances 0.000 description 5
- 238000011160 research Methods 0.000 description 5
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 4
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 238000011161 development Methods 0.000 description 4
- 239000012634 fragment Substances 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 241001446247 uncultured actinomycete Species 0.000 description 4
- 101000925662 Enterobacteria phage PRD1 Endolysin Proteins 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 3
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 239000000499 gel Substances 0.000 description 3
- 239000006166 lysate Substances 0.000 description 3
- 244000005700 microbiome Species 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 210000001938 protoplast Anatomy 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 3
- 241000186361 Actinobacteria <class> Species 0.000 description 2
- 229920000936 Agarose Polymers 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 102000053602 DNA Human genes 0.000 description 2
- 239000004471 Glycine Substances 0.000 description 2
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- 239000001888 Peptone Substances 0.000 description 2
- 108010080698 Peptones Proteins 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 239000007853 buffer solution Substances 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000013611 chromosomal DNA Substances 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 238000004925 denaturation Methods 0.000 description 2
- 230000036425 denaturation Effects 0.000 description 2
- ZMMJGEGLRURXTF-UHFFFAOYSA-N ethidium bromide Chemical compound [Br-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 ZMMJGEGLRURXTF-UHFFFAOYSA-N 0.000 description 2
- 229960005542 ethidium bromide Drugs 0.000 description 2
- 238000005194 fractionation Methods 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 239000012535 impurity Substances 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- KWGKDLIKAYFUFQ-UHFFFAOYSA-M lithium chloride Chemical compound [Li+].[Cl-] KWGKDLIKAYFUFQ-UHFFFAOYSA-M 0.000 description 2
- 235000019319 peptone Nutrition 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 238000005185 salting out Methods 0.000 description 2
- 235000002639 sodium chloride Nutrition 0.000 description 2
- VWDWKYIASSYTQR-UHFFFAOYSA-N sodium nitrate Chemical compound [Na+].[O-][N+]([O-])=O VWDWKYIASSYTQR-UHFFFAOYSA-N 0.000 description 2
- PFNFFQXMRSDOHW-UHFFFAOYSA-N spermine Chemical compound NCCCNCCCCNCCCN PFNFFQXMRSDOHW-UHFFFAOYSA-N 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 2
- XDIYNQZUNSSENW-UUBOPVPUSA-N (2R,3S,4R,5R)-2,3,4,5,6-pentahydroxyhexanal Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O XDIYNQZUNSSENW-UUBOPVPUSA-N 0.000 description 1
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 1
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- RFSUNEUAIZKAJO-VRPWFDPXSA-N D-Fructose Natural products OC[C@H]1OC(O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-VRPWFDPXSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 description 1
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- -1 If necessary Chemical class 0.000 description 1
- PNNNRSAQSRJVSB-UHFFFAOYSA-N L-rhamnose Natural products CC(O)C(O)C(O)C(O)C=O PNNNRSAQSRJVSB-UHFFFAOYSA-N 0.000 description 1
- 102000003960 Ligases Human genes 0.000 description 1
- 108090000364 Ligases Proteins 0.000 description 1
- 108010014251 Muramidase Proteins 0.000 description 1
- 102000016943 Muramidase Human genes 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 description 1
- 240000004713 Pisum sativum Species 0.000 description 1
- 235000010582 Pisum sativum Nutrition 0.000 description 1
- MUPFEKGTMRGPLJ-RMMQSMQOSA-N Raffinose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 MUPFEKGTMRGPLJ-RMMQSMQOSA-N 0.000 description 1
- 241000576755 Sclerotia Species 0.000 description 1
- 241000187180 Streptomyces sp. Species 0.000 description 1
- 239000007984 Tris EDTA buffer Substances 0.000 description 1
- MUPFEKGTMRGPLJ-UHFFFAOYSA-N UNPD196149 Natural products OC1C(O)C(CO)OC1(CO)OC1C(O)C(O)C(O)C(COC2C(C(O)C(O)C(CO)O2)O)O1 MUPFEKGTMRGPLJ-UHFFFAOYSA-N 0.000 description 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 238000000246 agarose gel electrophoresis Methods 0.000 description 1
- 239000003905 agrochemical Substances 0.000 description 1
- PNNNRSAQSRJVSB-BXKVDMCESA-N aldehydo-L-rhamnose Chemical compound C[C@H](O)[C@H](O)[C@@H](O)[C@@H](O)C=O PNNNRSAQSRJVSB-BXKVDMCESA-N 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 235000011130 ammonium sulphate Nutrition 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- AIYUHDOJVYHVIT-UHFFFAOYSA-M caesium chloride Chemical compound [Cl-].[Cs+] AIYUHDOJVYHVIT-UHFFFAOYSA-M 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 235000010216 calcium carbonate Nutrition 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 235000013877 carbamide Nutrition 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 210000000349 chromosome Anatomy 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 239000011790 ferrous sulphate Substances 0.000 description 1
- 235000003891 ferrous sulphate Nutrition 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 229910017053 inorganic salt Inorganic materials 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 description 1
- 229910000359 iron(II) sulfate Inorganic materials 0.000 description 1
- 230000001678 irradiating effect Effects 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 238000009630 liquid culture Methods 0.000 description 1
- 229960000274 lysozyme Drugs 0.000 description 1
- 239000004325 lysozyme Substances 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 230000002906 microbiologic effect Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 239000006877 oatmeal agar Substances 0.000 description 1
- 125000001477 organic nitrogen group Chemical group 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 239000013600 plasmid vector Substances 0.000 description 1
- 238000004262 preparative liquid chromatography Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- MUPFEKGTMRGPLJ-ZQSKZDJDSA-N raffinose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)O1 MUPFEKGTMRGPLJ-ZQSKZDJDSA-N 0.000 description 1
- 230000006798 recombination Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 108700004121 sarkosyl Proteins 0.000 description 1
- 239000013049 sediment Substances 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 235000020183 skimmed milk Nutrition 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- KSAVQLQVUXSOCR-UHFFFAOYSA-M sodium lauroyl sarcosinate Chemical compound [Na+].CCCCCCCCCCCC(=O)N(C)CC([O-])=O KSAVQLQVUXSOCR-UHFFFAOYSA-M 0.000 description 1
- 235000010344 sodium nitrate Nutrition 0.000 description 1
- 239000004317 sodium nitrate Substances 0.000 description 1
- 229940063675 spermine Drugs 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical class [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 1
- 239000012137 tryptone Substances 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
- C12N15/76—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Actinomyces; for Streptomyces
Landscapes
- Genetics & Genomics (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
Abstract
Description
【発明の詳細な説明】
〔産業上の利用分野〕
本発明はストレプトミセス属に属する放線菌の含有する
新規多コピー性プラスミド及びこれに各種の薬剤耐性遺
伝子等の外来DNAを組み込んだ組換え体プラスミドに
関するものである。Detailed Description of the Invention [Field of Industrial Application] The present invention relates to a novel multicopy plasmid contained in an actinomycete belonging to the genus Streptomyces and a recombinant product incorporating foreign DNA such as various drug resistance genes into this plasmid. It concerns plasmids.
微生物の生産する抗生物質等の各種生理活性物質の多く
は、放線菌なかでもストレプトミセス属に属する菌株の
培養物から造られており、ストレプトミセス属は有用な
微生物として位置づけがなされている。近年、バイオテ
クノロジーの発展と共に、ストレプトミセス属に関する
遺伝子組換え研究が盛んに行われているが、それに使用
できるプラスミドベクターの開発は充分でなく、研究の
進行の上で妨げとなっている。とりわけ宿主細胞内での
複製性に優れたいわゆる多コピー性プラスミドは物質生
産等のうえで必須でありその開発が待たれている。Many of the various physiologically active substances such as antibiotics produced by microorganisms are produced from cultures of strains belonging to the genus Streptomyces among actinomycetes, and the genus Streptomyces is positioned as a useful microorganism. In recent years, with the development of biotechnology, genetic recombination research on the genus Streptomyces has been actively conducted, but the development of plasmid vectors that can be used for this has not been sufficient, which has hindered the progress of research. In particular, so-called multicopy plasmids, which have excellent replication properties within host cells, are essential for substance production, and their development is eagerly awaited.
これまでに知られる放線菌プラスミドとしては、Mo、
1ecular and General Genet
ics 185+ 223−238(1982)に記載
のp I J −101(8,9キロベース)。Actinomycete plasmids known so far include Mo,
1Ecular and General Genet
ics 185+ 223-238 (1982).
Journal or General Microb
iology 129+ 2703−2714(198
3)に記載のp I J −702(5,8キロベース
)。Journal or General Microb
iology 129+ 2703-2714 (198
p I J -702 (5,8 kilobase) described in 3).
Journal of General Microb
iology 132+ 2071−2078(198
6)に記載のρJ V −1(10,8キロベース)。Journal of General Microb
iology 132+ 2071-2078 (198
ρJ V −1 (10,8 kilobases) described in 6).
特開昭57−188600号記載のpS F588(3
,0メガダルトン)、特開昭58−24594号記載の
ps V H1(12,6キロベース)、 特開昭58
−43997号記載のpSLA3 (5,9ないし6.
4メガダルトン)、特開昭58−157800号記載の
pS A N181(5,0メガダルトン)、 特開昭
59−74989号記載のpo FOII(5,2ない
し5.3メガダルトン)、特開昭59−143588号
記載のpOAll(10,8キロベース)、特開昭59
466088号記載のpN Mloo(9,1キロベー
ス)、 特開昭60−207584号記載のps N2
2(11,5キロベース)、 特開昭60−21488
5号記載のp F J 301 (13,7キロベース
)、 特開昭60−256384号記載のps G 5
(12,7キロベース)ならびに特開昭61−124
386号記載のpBTl(5,6キロヘース)等が挙げ
られるが何れも産業的利用において、プラスミドのコピ
ー数において満足しているとは言い難い。pSF588(3) described in JP-A-57-188600
, 0 megadalton), ps V H1 (12.6 kilobase) described in JP-A-58-24594, JP-A-58-24594
pSLA3 described in No.-43997 (5, 9 to 6.
pS A N181 (5,0 megadaltons) described in JP-A No. 58-157800 (5,0 megadaltons), po FOII (5,2 to 5.3 megadaltons) described in JP-A-59-74989, pOAll (10.8 kilobase) described in No. 59-143588, JP-A-59
pN Mloo (9,1 kilobase) described in No. 466088, ps N2 described in JP-A-60-207584
2 (11.5 kilobase), JP-A-60-21488
pF J 301 (13.7 kilobase) described in No. 5, ps G 5 described in JP-A-60-256384
(12.7 kilobase) and JP-A-61-124
Examples include pBTl (5,6 kilohose) described in No. 386, but it cannot be said that the copy number of the plasmid is satisfactory for industrial use.
一般的な放線菌プラスミドのコピー数は数10コピーと
いわれており、多コピー性プラスミドとして知られるも
のには前述のp I J−101(40ないし300コ
ピー)、 p I J−702(40ないし300コピ
ー)。The copy number of general actinomycete plasmids is said to be several tens of copies, and those known as multicopy plasmids include the aforementioned pI J-101 (40 to 300 copies) and pI J-702 (40 to 300 copies). 300 copies).
ならびにp、y V −1(150コピー)等が有るが
、これらのコピー数では物質生産を目的とするには必ず
しも充分なコピー性能とは称し難い。そこで本発明者ら
は多コピー性の性質を備えたストレプトミセス属放線菌
を宿主とする新規プラスミドの開発を本発明の目的とし
た。and p, y V -1 (150 copies), but these copy numbers cannot necessarily be called sufficient copy performance for the purpose of substance production. Therefore, the present inventors aimed at developing a new plasmid that uses Streptomyces sp. actinomycetes as a host and has multicopy properties.
本発明者等は保有のストレプトミセス属に属する多くの
菌株から有望なプラスミドの検索を進めた結果、特異的
に多量のプラスミドを有する菌株の選出に成功し、同株
のプラスミドを単離し検討の結果、本プラスミドが極め
て高いコピー性能を確認し本発明の完成に至った。As a result of searching for promising plasmids from the many strains belonging to the genus Streptomyces, the present inventors succeeded in selecting a strain with a specifically large amount of plasmid, isolated the plasmid of the strain, and conducted an investigation. As a result, it was confirmed that this plasmid had extremely high copying performance, leading to the completion of the present invention.
本発明者等はストレプトミセス属に属するKSA、−6
233株をストレプトミセス ビオラセオニガ−(St
reptomyces Violaceoniger)
と同定し島その培養菌体から単離したプラスミドをpN
B701と命名した。pN8701は、約10.2キロ
ベースの分子量を有する新規プラスミドであり、6塩基
認識の制限酵素に多くの切断点を持ち、かつ宿主細胞中
での複製能が高いいわゆる多コピープラスミドである。The present inventors have discovered that KSA, -6, which belongs to the genus Streptomyces,
233 strains of Streptomyces violaceoniger (St
reptomyces violaceoniger)
The plasmid isolated from the cultured bacterial cells was identified as pN.
It was named B701. pN8701 is a novel plasmid with a molecular weight of approximately 10.2 kilobases, and is a so-called multicopy plasmid that has many cleavage points for restriction enzymes that recognize six bases and has high replication ability in host cells.
また、前記プラスミドpNB701に、一般的なりNA
操作技術により、外来遺伝子を組み込むことにより、多
コピー性の組換え体プラスミドを得ることができる。In addition, in the plasmid pNB701, a general
By incorporating foreign genes through manipulation techniques, multicopy recombinant plasmids can be obtained.
即ち本発明は約10.2キロベースの分子量を有し、か
つ第1図で示される制限酵素切断点を有することを特徴
とするプラスミドpNB701及びこれに外来遺伝子を
組み込んでなる組換え体プラスミドに関するものである
。Specifically, the present invention relates to plasmid pNB701, which has a molecular weight of about 10.2 kilobases and has the restriction enzyme cleavage point shown in FIG. 1, and a recombinant plasmid obtained by incorporating a foreign gene into this plasmid It is something.
以下実施例を含めて本発明の内容を詳細に説明する。The contents of the present invention will be explained in detail below, including examples.
NB701木−〇凸2
pNB701を保有する放線菌K S A6233に付
いての菌学的性質は以下の通りである。NB701 Tree-〇Convex 2 The mycological properties of actinomycete KSA6233 harboring pNB701 are as follows.
(11形態
基底菌糸はよく分岐しながらジグザグ状を呈し分断は見
られない。気菌糸はスターチ無機塩寒天培地、チロシン
寒天培地、イースト麦芽寒天培地及びオートミール寒天
培地等で豊富に着生し、胞子形成も良好であるが、培養
後!tIl(14〜21日培養)に気菌糸上に湿った黒
色部分いわゆるハイグロスコピックエリヤが出現する。(11 Morphology Basal hyphae exhibit a zigzag shape with good branching, and no divisions are observed. Aerial hyphae are abundantly attached to starch inorganic salt agar, tyrosine agar, yeast malt agar, oatmeal agar, etc., and spores are formed. Although the formation is good, a moist black area called hygroscopic area appears on the aerial mycelia after !tIl (14 to 21 days of culture).
気菌糸は車軸分岐し、胞子鎖は螺旋状で先端がコンパク
トな螺旋状となっているものが多り、10〜50個以上
の胞子からなっている。胞子表面は平滑で、大きさ0.
6〜0.8 X 1. O〜1.4ミクロンの長円形で
ある。菌核、胞子光、運動性胞子などの特殊形態は観察
されない。全菌体加水分解物はLL−ジアミノピメリン
酸を含む。Aerial hyphae are axle-branched, and the spore chain is often spiral-shaped with a compact spiral tip, and consists of 10 to 50 or more spores. The spore surface is smooth and the size is 0.
6-0.8 x 1. It has an oval shape of 0 to 1.4 microns. Special forms such as sclerotia, spore lights, and motile spores are not observed. The whole bacterial cell hydrolyzate contains LL-diaminopimelic acid.
(3)各種培地における生育状態 培養3週間目の生育状態は第1表に示す通りである。(3) Growth status in various media The growth status after 3 weeks of culture is as shown in Table 1.
(来夏以下余白)
第1表
表中括弧内にカラーハーモニーマニュアルの色素コード
を示す(2)生理的性質
■ 生育温度範囲 20から40℃最適温度範
囲 25から35℃■ゼラチンの液化
十
■スターチの加水分解 十
■脱脂牛乳の凝固 −
ペプトン化 十
■メラニン様色素の生成
チロシン寒天培地 十ペプ
トン、イースト・&’N 天培地 +トリプ
トン・イースト液体培地 十(4)各
炭素源の同化性(ブリトハム・ゴFIJ−プ寒天培地上
)同化する炭素源 L−7ラピノース、
D−キ河−ス。(Leaving space below next summer) Table 1 The color harmony manual color codes are shown in brackets (2) Physiological properties ■ Growth temperature range 20 to 40℃ Optimum temperature range 25 to 35℃ ■ Liquefaction of gelatin
10 ■ Hydrolysis of starch 10 ■ Coagulation of skimmed milk - peptonization 10 ■ Production of melanin-like pigment Tyrosine agar medium 10 Peptone, yeast &'N heaven medium + tryptone yeast liquid medium 10 (4) Assimilation of each carbon source Assimilable carbon source L-7 rapinose (on Britham GoFIJ-P agar)
D-ki river-su.
D−グルコース、 D−フラクトースシュクロース
、 L−ラムノース。D-glucose, D-fructose sucrose, L-rhamnose.
ラフィノース、 D−マンニット。Raffinose, D-Mannit.
同化しない炭化源 ■−イノシトール得られた上記の
菌学的性質をInternationalJourna
l of Systematic Bacterto、
1ogy+ 22巻、364−366頁(1972)を
参照に同定をした結果、KSA−6233はストレプミ
セスビオラセオニガ−(Stre−ptomyces
vtolaceoniger)と僅かな差異、つまりメ
ラニン様色素の生成とI−イノシトールの利用性の2点
とがあるが、それを除けば最も近縁であると思われる。Non-assimilable carbonized source ■-Inositol The above mycological properties obtained are reported in the International Journal.
l of Systematic Bacterto,
1ogy+ Vol. 22, pp. 364-366 (1972), KSA-6233 was identified as Streptomyces violaceoniger.
Vtolaceoniger) and there are two slight differences, namely the production of melanin-like pigments and the availability of I-inositol, but other than these, they are considered to be the most closely related.
よって本菌株をストレプトミセス ビオラセオニガーK
S A−6233(Streptomyces vi
olaceonigerKSA−6233) と命名
する。Therefore, this strain is Streptomyces violaceoniger K.
S A-6233 (Streptomyces vi
olaceonigerKSA-6233).
なお、本菌株、ストレプトミセス ビオラセオニガーK
S A−6233は工業技術院微生物工業技術研究所
に微工研菌寄第9233として寄託されている。In addition, this strain, Streptomyces violaceoniger K.
S A-6233 has been deposited with the Institute of Microbial Technology, Agency of Industrial Science and Technology as Microbiological Research Institute Deposit No. 9233.
」Σ1刀lΔ」袈
次に多コピープラスミドpNB701の調製法について
述べる。ストレプトミセス ビオラセオニガーに属しp
NB701を持つ菌株例えばKSA−6233株を培養
しその菌体を集め、溶菌酵素等により溶解後、溶解液区
分からRNA、タンパク質等のきょう雑物質を取り除い
た後、密度勾配超遠心法または電気泳動アガロースゲル
の切り出し法等の分離操作により目的とするプラスミド
pNB701を単離することが出来る。本操作は微生物
からのプラスミドの採取法としての常法である。また、
Nucleic Ac1ds Re5earch、
9巻、20号、 5493〜5504頁(1981)に
記載のようにスペルミン処理により2本鎖DNAを不溶
化せしめ回収する簡易的手段を採用することも可能であ
る。以下ρNB701調製の各操作に付その内容を記載
する。"Σ1 sword lΔ" Keji describes the preparation method of multi-copy plasmid pNB701. Belongs to Streptomyces violaceoniger p.
A bacterial strain containing NB701, such as the KSA-6233 strain, is cultured, the bacterial cells are collected, lysed with a lytic enzyme, etc., and contaminants such as RNA and proteins are removed from the lysate, followed by density gradient ultracentrifugation or electrophoresis. The target plasmid pNB701 can be isolated by a separation operation such as an agarose gel excision method. This operation is a standard method for collecting plasmids from microorganisms. Also,
Nucleic Ac1ds Research,
9, No. 20, pp. 5493-5504 (1981), it is also possible to employ a simple method of insolubilizing and recovering double-stranded DNA by treatment with spermine. The details of each operation for preparing ρNB701 will be described below.
(1) K S A−6233株の培養木閑の培養は
一般的放線菌の液体培養法が適用される。即ち、グルコ
ース、シュクロース等の糖質にペプトン、酵母エキス、
肉エキス等の有機窒素源または硫酸アンモン、尿素、硝
酸す1− IJウム等の無機窒素源を単独もしくは組み
合わせて用い、更にリン酸カリウム塩類、硫酸マグネシ
ウム、塩化ナトリウム、炭酸カルシウム、硫酸第1鉄等
の無機塩類を加えた液体培地に培養する。必要に応じて
溶菌酵素の感受性を高めるためグリシン等のアミノ酸の
添加も有効である。TSBG培地やGPYG培地のよう
な既知組成培地を用いてもよい。培養は25ないし35
°Cの温度にて12ないし48時間行うことが好ましい
。(1) Cultivation of KSA-6233 strain A general liquid culture method for actinomycetes is applied to the cultivation of Mokkan. That is, carbohydrates such as glucose and sucrose, peptone, yeast extract,
Organic nitrogen sources such as meat extract or inorganic nitrogen sources such as ammonium sulfate, urea, and sodium nitrate are used alone or in combination, and potassium phosphate salts, magnesium sulfate, sodium chloride, calcium carbonate, and ferrous sulfate are used. Culture in a liquid medium supplemented with inorganic salts such as If necessary, it is also effective to add amino acids such as glycine to increase the sensitivity of the lytic enzyme. A chemically defined medium such as TSBG medium or GPYG medium may also be used. Culture is 25 to 35
Preferably, the reaction is carried out at a temperature of 12 to 48 hours.
培養菌体は遠心分離して集め洗浄操作を加える。The cultured bacterial cells are collected by centrifugation and washed.
(2)粗プラスミドの調製
洗浄菌体をリゾチーム等の溶菌酵素を用いてプロトプラ
スト化し、N−ラウロイルサルコシン酸ナトリウム(S
LS)やラウリル硫酸ナトリウム(SDS)等を加えて
溶菌後、アルカリ変性、塩析、フェノール変性等の操作
により染色体DNAや残存菌体成分及びタンパク質等を
除去後、冷アルコールを加えて生ずる沈澱物を粗プラス
ミドとして回収する。共存するRNAの除去のためRN
ase反応を回収行程の途中に加えることも出来る。(2) Preparation of crude plasmid The washed bacterial cells were made into protoplasts using a lytic enzyme such as lysozyme, and sodium N-lauroylsarcosinate (S
After lysis by adding LS) or sodium lauryl sulfate (SDS), etc., remove chromosomal DNA, residual bacterial components, proteins, etc. by operations such as alkaline denaturation, salting out, and phenol denaturation, and then add cold alcohol to form a precipitate. is recovered as a crude plasmid. RN for removal of coexisting RNA
It is also possible to add an ase reaction during the recovery process.
(31pNB701の単離
目的とするプラスミドpNB701は上述の粗プラスミ
ドをアガロース電気泳動法または塩化セシウムを用いた
密度勾配超遠心法などのDNA分画法により単離回収で
きる。一般的には微量回収には前者を、星的回収には後
者を用いるがこれらに限定されることなく分取液体クロ
マトグラフィー法等のDNA分画手段によってもよい。(Isolation of 31pNB701 The target plasmid pNB701 can be isolated and recovered from the crude plasmid described above by DNA fractionation methods such as agarose electrophoresis or density gradient ultracentrifugation using cesium chloride.Generally, a trace amount is recovered. The former is used for sterile recovery, and the latter is used for star recovery, but DNA fractionation means such as preparative liquid chromatography may also be used, without being limited thereto.
」ΣB701Δ届近
得られたpNB701の解析は常法の制限酵素切断点地
図の作成に準じて行うことが出来る。即ち制限酵素によ
るpNB701の分解によって得られたDNA断片のア
ガロースゲル電気泳動による解析から各種制限酵素に対
する切断部位数ならびにDNA断片の大きさを求められ
る。又、制限酵素の組合せからえられるDNA断片の大
きさの解析情報を併せれば制限酵素切断点地図の決定が
可能である。またコピー数の決定は溶菌液のアガロース
電気泳動ゲルをエチジウムプロミドで染色後紫外線照射
により発色し、ネガフィルムに写した後、同フィルムの
デンシトメーターによる計測から染色体DNAfiとの
対比による常法により行うことができる。尚、染色体D
NAは104キロベースとして算出基準とする。"ΣB701Δ Notification" Analysis of the obtained pNB701 can be performed according to the conventional method of creating a restriction enzyme breakpoint map. That is, the number of cleavage sites for various restriction enzymes and the size of the DNA fragments can be determined from agarose gel electrophoresis analysis of DNA fragments obtained by digestion of pNB701 with restriction enzymes. Furthermore, by combining analysis information on the size of DNA fragments obtained from combinations of restriction enzymes, it is possible to determine a restriction enzyme breakpoint map. The copy number can also be determined using the conventional method by staining an agarose electrophoresis gel of the lysate with ethidium bromide, developing the color by irradiating it with ultraviolet rays, transferring it to a negative film, measuring the same film with a densitometer, and comparing it with the chromosomal DNA fi. This can be done by Furthermore, chromosome D
NA is calculated based on 104 km base.
これらの方法により解析結果を取りまとめると以下の記
載となる。The analysis results obtained using these methods are summarized as follows.
(」)プラスミドpNB701の大きさ分子量約10.
2キロベースのデオキシリボ核酸である。('') Size and molecular weight of plasmid pNB701: approximately 10.
It is a 2 kilobase deoxyribonucleic acid.
(2)制限酵素切断部位数 各制限酵素に対し以下の切断部位数を持つ。(2) Number of restriction enzyme cleavage sites Each restriction enzyme has the following number of cleavage sites.
Bcl I 2M1u I
2Stu 1
1
Pvu II 4H4nd m
I
Bgl II 2
Apa I 2
(3)制限酵素切断点地図
第1図に記載の通り。Bcl I 2M1u I
2Stu 1
1 Pvu II 4H4nd m
I Bgl II 2 Apa I 2 (3) Restriction enzyme breakpoint map As shown in FIG.
(4) コピー数
次に本発明プラスミドの多コピー性を試験結果を以て証
明する。(4) Copy number Next, the multicopy nature of the plasmid of the present invention will be demonstrated using test results.
pNB701 400ないし750コビーpl
J702(対照)50ないし100コピー又、GINB
701に外来遺伝子を挿入し組換え体プラスミドの創製
は一般的なりNA操作技術により可能である。即ち上述
の制限酵素を用いてプラスミドの一部を開列し、必要に
応じてアルカリフォスファクーゼ処理して自己修復を抑
えた後に、薬剤耐性遺伝子の様な外来DNAをリガーゼ
を用いてプラスミドの修復を行えば、外来DNAが組み
込まれたりコンビナンドプラスミドが得られる。pNB701 400 to 750 coby pl
J702 (control) 50 to 100 copies and GINB
It is possible to insert a foreign gene into 701 and create a recombinant plasmid using general NA manipulation techniques. That is, a part of the plasmid is opened using the above-mentioned restriction enzymes, and if necessary, it is treated with alkaline phosphatase to suppress self-repair, and then foreign DNA such as a drug resistance gene is repaired using ligase. By doing this, foreign DNA can be integrated or a combinant plasmid can be obtained.
これら組換え体プラスミドは外来DNAの機能をマーカ
ーとして選抜することが出来る。制限酵素処理の際プラ
スミドが複数に切断された場合にはpN8701のDN
A断片の一部に外来DNAが組み込まれた組換え体プラ
スミドが得られることもある。これらの組換え体プラス
ミドはpNB701にその複製機能を依存するもので多
コピー性の性質が継承される。These recombinant plasmids can be selected using the function of the foreign DNA as a marker. If the plasmid is cut into multiple parts during restriction enzyme treatment, the DNA of pN8701
A recombinant plasmid may be obtained in which foreign DNA is integrated into a portion of the A fragment. These recombinant plasmids depend on pNB701 for their replication function and inherit the multicopy property.
実施例1 pNB701の調製
ストレプトミセス ビオラセオニガー KSA6233
からのプラスミドpNB701の調製は以下の方法によ
った。Example 1 Preparation of pNB701 Streptomyces violaceoniger KSA6233
Plasmid pNB701 was prepared from the following method.
K S A6233は5dのTSBG培地(3%7ry
pticSoy Broth(Dirco)、 1%
グルコース)とガラスピーズを入れた21印試験管で振
とう培養を行い、28℃で1〜2日間培養したものを種
母とした。本培養は500 rnlの三角フラスコを用
いて0.2%のグリシンを添加したTSBG培地100
dの振とう培養を28℃で36時間行った。培養液を冷
却遠心骨N機にかけ菌体(湿重量約3g)を回収し、次
いでpH8,07EG緩衝液(25mM Tris−H
Cl、16mM EDTA−2Na)50mMグルコー
スで菌体を洗浄した。再度TEG緩衝液10m1に菌体
を懸濁した後2dのりゾチーム液(30■/−)を加え
て37℃で保温しプロトプラストを形成させた。プロト
プラストは25%SDS溶液2ml及び0.36N−N
aOH液10m1を加えて溶菌させた。次いで、この溶
菌液に6.5rnlの5M−塩化リチウムを添加して塩
析し、遠心分離して得た上澄を更にフェノール、クロロ
ホルムで変性抽出することによって不純物を除去した後
、冷エタノールを加えて沈澱物を回収した。沈澱物を0
.5 mffのTE緩衝液に溶解したプラスミド溶液に
1%RNasc溶液10μβを加えて37℃にて15分
反応しRNAを分解後、フェノール、クロロホルム処理
にょすRN ascを変性除去した。目的のプラスミド
を回収するために、残ったプラスミド溶液を0.7%の
アガロースゲルにアプライしてスラブ型電気泳動にかけ
、泳動ゲルをエチジウムプロミドで染色した後UV照躬
にて観察して、pNB701のバンドをカッターで切り
だした。このゲル切片を緩衝液と共に透析膜に封じてサ
ブマリン型泳動槽に沈めて泳動を行い緩衝液中にプラス
ミドを溶出して、フェノール、クロロホルム処理により
不純物を除去した後、冷エタノールを加えて回収した。KSA6233 was prepared using 5d TSBG medium (3% 7ry
pticSoy Broth (Dirco), 1%
A shaking culture was performed in a 21-mark test tube containing glucose (glucose) and glass peas, and the seeds were cultured at 28°C for 1 to 2 days. The main culture was carried out using a 500 rnl Erlenmeyer flask in 100% TSBG medium supplemented with 0.2% glycine.
The shaking culture of d was performed at 28°C for 36 hours. The culture solution was applied to a refrigerated centrifugal bone N machine to collect bacterial cells (wet weight: about 3 g), and then added to pH 8,07 EG buffer (25 mM Tris-H
The bacterial cells were washed with Cl, 16mM EDTA-2Na) and 50mM glucose. After suspending the bacterial cells in 10 ml of TEG buffer again, 2 d of Norizozyme solution (30 μ/-) was added and kept at 37° C. to form protoplasts. Protoplasts were prepared using 2 ml of 25% SDS solution and 0.36 N-N
10 ml of aOH solution was added to lyse the bacteria. Next, 6.5rnl of 5M lithium chloride was added to this lysate for salting out, and the supernatant obtained by centrifugation was further denatured and extracted with phenol and chloroform to remove impurities, and then cold ethanol was added. In addition, a precipitate was collected. 0 sediment
.. 10 μβ of a 1% RN asc solution was added to a plasmid solution dissolved in 5 mff of TE buffer, and the mixture was reacted at 37° C. for 15 minutes to degrade the RNA. After treatment with phenol and chloroform, the RN asc was denatured and removed. In order to recover the desired plasmid, the remaining plasmid solution was applied to a 0.7% agarose gel and subjected to slab electrophoresis, and the electrophoresis gel was stained with ethidium bromide and observed under UV light. The pNB701 band was cut out with a cutter. This gel section was sealed in a dialysis membrane along with a buffer solution and submerged in a submarine-type electrophoresis tank for electrophoresis.The plasmid was eluted into the buffer solution, impurities were removed by treatment with phenol and chloroform, and then collected by adding cold ethanol. .
得られたプラスミドは35〜40μgであり電気泳動的
に単一であることを確認した。The obtained plasmid weighed 35 to 40 μg and was electrophoretically confirmed to be single.
以上記載したように、本発明の新規プラスミドpNB7
01はストレプトミセス属の宿主細胞内でプラスミドの
複製を高頻度に行う多コピー性プラスミドであり、スト
レプトミセス属における目的DNAのクローニングや、
物質生産遺伝子とプラスミドとの組換え体を用いて物質
生産を行うために極めて重要なベクターとしての役割が
期待される。As described above, the novel plasmid pNB7 of the present invention
01 is a multicopy plasmid that replicates at high frequency in host cells of the genus Streptomyces, and is useful for cloning of target DNA in the genus Streptomyces,
It is expected to play an extremely important role as a vector for producing substances using recombinants of substance-producing genes and plasmids.
また、前記プラスミドpNB701から得られた本発明
の組換え体プラスミドは、前記プラスミドpNB701
の有する多コピー性をそのまま維持しており、物質生産
性の観点等から極めて有用である。Furthermore, the recombinant plasmid of the present invention obtained from the plasmid pNB701 is the plasmid pNB701.
It maintains the multi-copy property of , and is extremely useful from the viewpoint of material productivity.
第1図はpNB701の制限酵素による切断地図である
。
出願人 農薬バイオテクノロジー
開発技術研究組合FIG. 1 is a restriction enzyme cleavage map of pNB701. Applicant Agrochemical Biotechnology Development Technology Research Association
Claims (1)
制限酵素地図に示した制限酵素切断点を有することを特
徴とするプラスミドpNB−701。 ▲数式、化学式、表等があります▼ 2、プラスミドpNB−701に外来遺伝子を組み込ん
でなる組換え体プラスミド。 3、外来遺伝子が薬剤耐性遺伝子であることを特徴とす
る特許請求の範囲第2項記載の組換え体プラスミド。[Scope of Claims] 1. Plasmid pNB-701, which has a molecular weight of about 10.2 kilobases and has a restriction enzyme cleavage point shown in the restriction enzyme map below. ▲There are mathematical formulas, chemical formulas, tables, etc.▼ 2. A recombinant plasmid made by incorporating a foreign gene into plasmid pNB-701. 3. The recombinant plasmid according to claim 2, wherein the foreign gene is a drug resistance gene.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP62070217A JPH074260B2 (en) | 1987-03-26 | 1987-03-26 | Novel multicopy plasmid |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP62070217A JPH074260B2 (en) | 1987-03-26 | 1987-03-26 | Novel multicopy plasmid |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS63237788A true JPS63237788A (en) | 1988-10-04 |
JPH074260B2 JPH074260B2 (en) | 1995-01-25 |
Family
ID=13425153
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP62070217A Expired - Fee Related JPH074260B2 (en) | 1987-03-26 | 1987-03-26 | Novel multicopy plasmid |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH074260B2 (en) |
-
1987
- 1987-03-26 JP JP62070217A patent/JPH074260B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
JPH074260B2 (en) | 1995-01-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Walder et al. | Cloning and expression of the Pst I restriction-modification system in Escherichia coli. | |
US4649119A (en) | Cloning systems for corynebacterium | |
JP3289726B2 (en) | Clavalanic acid biosynthesis gene | |
GB1588572A (en) | Process for the production of filamentous hybrid phages | |
CN116042572B (en) | Application of xCas12a protein or related biomaterials | |
JPS63237788A (en) | Novel multi-copying plasmid | |
JPH0363357B2 (en) | ||
EP0179025A1 (en) | Method for the production of neutral protease | |
JPS62262994A (en) | D-amino acid oxidase gene | |
US5705386A (en) | Circular plasmids | |
JP2615090B2 (en) | Plasmids and Escherichia coli transformed therewith | |
FR2464998A1 (en) | NEW PLASMID AND USE THEREOF FOR MODIFYING E. COLI STRAIN | |
JPS61502799A (en) | Recombinant DNA molecules, transformed microorganisms, and methods for producing penicillin V amidase | |
JP3014717B2 (en) | DNA fragment encoding purine nucleoside phosphorylase | |
JP2777947B2 (en) | Nsp7524V restriction / modification enzyme gene and production method | |
JPH0856669A (en) | New shuttle vector plasmid | |
JPH0568567A (en) | Gene coded about candida albicans cell membrane (h) atpase | |
JP2602840B2 (en) | Plasmids and Escherichia coli transformed therewith | |
JPS63222692A (en) | Novel multicopy plasmid and its production method | |
JPS62275684A (en) | Recombinant vector and bacterial cell containing same | |
JP2788070B2 (en) | 2-haloacid dehalogenase producing gene | |
JPS59159778A (en) | Preparation of heat-resistant leucine dehydrogenase | |
JPH0691825B2 (en) | Streptomyces cosmid vector | |
JPH074239B2 (en) | Method for producing thermostable leucine dehydrogenase | |
JP2001252088A (en) | Gene encoding creatine amidinohydrase |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
LAPS | Cancellation because of no payment of annual fees |